Business Context and Reporting Period
This Form 8-K Current Report was filed by TherapeuticsMD, Inc. on February 18, 2022, covering events occurring on February 17, 2022. The Company is a Nevada corporation with its principal executive office in Boca Raton, Florida, and its common stock trades on The Nasdaq Stock Market LLC under the symbol TXMD.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On February 17, 2022, Mr. Robert G. Finizio resigned from the Board of Directors and his position as Vice Chair, effective immediately. The Company stated that the resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the disclosure of the director's departure.
Investor Verification Checklist
- Confirm the effective date of Mr. Finizio's resignation (February 17, 2022).
- Verify if the Board has appointed a replacement for the Vice Chair position or a new director.
- Review subsequent filings for any impact on corporate strategy or governance structure.